BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 15999058)

  • 1. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
    Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
    Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
    Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study.
    Paci M; Cavazza A; Annessi V; Putrino I; Ferrari G; De Franco S; Sgarbi G
    Ann Thorac Surg; 2004 Apr; 77(4):1163-7. PubMed ID: 15063227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery.
    Doddoli C; Barlesi F; Chetaille B; Garbe L; Thomas P; Giudicelli R; Fuentes P
    Ann Thorac Surg; 2004 Apr; 77(4):1168-72. PubMed ID: 15063228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas.
    Ab' Saber AM; Massoni Neto LM; Bianchi CP; Ctenas BB; Parra ER; Eher EM; Pereira JC; Takagaki T; Yamaguchi NH; Capelozzi VL
    Ann Thorac Surg; 2004 Jun; 77(6):1883-90. PubMed ID: 15172229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity.
    Iyoda A; Hiroshima K; Moriya Y; Mizobuchi T; Otsuji M; Sekine Y; Shibuya K; Iizasa T; Saitoh Y; Fujisawa T
    Ann Thorac Surg; 2004 Jun; 77(6):1891-5; discussion 1895. PubMed ID: 15172230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants.
    Matsui K; Jin XM; Kitagawa M; Miwa A
    Arch Pathol Lab Med; 1998 Nov; 122(11):1010-7. PubMed ID: 9822131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
    Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
    Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
    Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recurrence and survival after surgical treatment of lung cancer].
    Hjelde H; Sundstrøm S; Ødegård A; Hatlinghus S; Abusland AB; Haaverstad R
    Tidsskr Nor Laegeforen; 2010 Jan; 130(1):25-8. PubMed ID: 20094119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behaviour and survival of high-grade neuroendocrine carcinomas of the lung.
    Naranjo Gómez JM; Gómez Román JJ
    Respir Med; 2010 Dec; 104(12):1929-36. PubMed ID: 20810262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis of surgically treated large cell neuroendocrine carcinoma].
    Matsuura N; Nakashima N; Igai H; Tarumi S; Chang SS; Misaki N; Liu D; Go T; Ishikawa S; Huang CL; Yokomise H
    Kyobu Geka; 2011 Mar; 64(3):187-90. PubMed ID: 21404553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy.
    Tanaka Y; Ogawa H; Uchino K; Ohbayashi C; Maniwa Y; Nishio W; Nakao A; Yoshimura M
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):839-46. PubMed ID: 22498090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
    Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
    Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroendocrine tumors of the lung].
    Oliaro A; Donati G; Filosso PL; Ruffini E
    Minerva Chir; 2000; 55(1-2):7-16. PubMed ID: 10832278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Important prognostic factors for the long-term survival of lung cancer subjects in Taiwan.
    Chiang TA; Chen PH; Wu PF; Wang TN; Chang PY; Ko AM; Huang MS; Ko YC
    BMC Cancer; 2008 Nov; 8():324. PubMed ID: 18992131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of resection for metachronous lung cancer.
    Battafarano RJ; Force SD; Meyers BF; Bell J; Guthrie TJ; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2004 Mar; 127(3):836-42. PubMed ID: 15001914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms.
    Ruffini E; Bongiovanni M; Cavallo A; Filosso PL; Giobbe R; Mancuso M; Molinatti M; Oliaro A
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):165-72. PubMed ID: 15200997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of preoperative radiotherapy on resection rate and long-term efficacy for patients with stage II and III lung carcinomas].
    Zhang LB; Zhou NK; Sun YE; Liu Y
    Ai Zheng; 2002 May; 21(5):514-7. PubMed ID: 12452043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.